Évolution des pratiques médicales d’hypofractionnement en radiothérapie pour cancer du sein et impact économique
Authors:
- 1 June 2016
- journal article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 20 (4) , 299-303
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Radiothérapie externe hypofractionnée du cancer du sein localisé : où en est-on ?Cancer/Radiothérapie, 2015
- Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacyRadiation Oncology, 2014
- Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapyAnnals of Oncology, 2014
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsThe Lancet Oncology, 2013
- Radiothérapie du cancer du sein infiltrant : recommandations nationales françaisesCancer/Radiothérapie, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based GuidelineInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerNew England Journal of Medicine, 2010
- The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet Oncology, 2008
- The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet, 2008